Education
About Us
Working with TipRanks
Follow Us
Alliance Pharma (GB:APH)
:APH
Total Valuation
Alliance Pharma has a market cap or net worth of £349.21M. The enterprise value is 310.64M.
Market Cap£349.21M
Enterprise Value310.64M
Share Statistics
Alliance Pharma has 540,565,550 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding540,565,550
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Alliance Pharma’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee623.03K
Profits Per Employee-114.26K
Employee Count290
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Alliance Pharma is ―. Alliance Pharma’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Alliance Pharma had revenue of 180.68M and earned -33.14M in profits. Earnings per share was -0.06.
Revenue180.68M
Gross Profit105.02M
Operating Income-38.44M
Pretax Income-48.80M
Net Income-33.14M
EBITDA-28.94M
Earnings Per Share (EPS)-0.06
Cash Flow
In the last 12 months, operating cash flow was 20.33M and capital expenditures -1.23M, giving a free cash flow of 19.11M billion.
Operating Cash Flow20.33M
Free Cash Flow19.11M
Free Cash Flow per Share0.04
Dividends & Yields
Alliance Pharma pays an annual dividend of 1.183p, resulting in a dividend yield of ―
Dividend Per Share1.183p
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.82
52-Week Price Change120.10%
50-Day Moving Average63.77
200-Day Moving Average50.85
Relative Strength Index (RSI)72.88
Average Volume (3m)2.76M
Important Dates
Alliance Pharma upcoming earnings date is Sep 30, 2025, TBA Not Confirmed.
Last Earnings DateApr 8, 2025
Next Earnings DateSep 30, 2025
Ex-Dividend DateJun 22, 2023
Financial Position
Alliance Pharma as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Alliance Pharma has paid -15.66M in taxes.
Income Tax-15.66M
Effective Tax Rate―
Enterprise Valuation
Alliance Pharma EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Alliance Pharma has £19.27M in cash and marketable securities with £113.65M in debt, giving a net cash position of £83.86M billion.
Cash & Marketable Securities£19.27M
Total Debt£113.65M
Net Cash£83.86M
Net Cash Per Share£0.16
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Alliance Pharma is £64.75, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target£64.75
Price Target Upside0.23% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-1.02%
EPS Growth Forecast67.70%